*** CHEMICAL IDENTIFICATION *** RTECS NUMBER : QC7800000 CHEMICAL NAME : Morphinan-3,14-diol, 17-(cyclopropylmethyl)- CAS REGISTRY NUMBER : 42281-59-4 LAST UPDATED : 199009 DATA ITEMS CITED : 4 MOLECULAR FORMULA : C20-H27-N-O2 MOLECULAR WEIGHT : 313.48 WISWESSER LINE NOTATION : T6 G666/FQ 2AF Q FX ONT&TTJ AQ IQ O1- AL3TJ COMPOUND DESCRIPTOR : Drug Human SYNONYMS/TRADE NAMES : * (L)-BC-2605 * Bristol laboratories BC 2605 * l-N-Cyclopropylmethyl-3,14-dihydroxymorphinan * (-)-17-Cyclopropylmethylmorphinan-3,4-diol * (-)-3,14-Dihydroxy-N-(cyclobutylmethyl)morphinan * Oxilorphan *** HEALTH HAZARD DATA *** ** ACUTE TOXICITY DATA ** TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human DOSE/DURATION : 14 ug/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Gastrointestinal - hypermotility, diarrhea Kidney, Ureter, Bladder - other changes REFERENCE : JCPCBR Journal of Clinical Pharmacology. (Hall Assoc., PO Box 482, Stamford, CT 06904) V.13- 1973- Volume(issue)/page/year: 16,183,1976 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Human DOSE/DURATION : 26 ug/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - tremor Behavioral - ataxia REFERENCE : DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 2,746,1977 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 315 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - tremor Behavioral - ataxia REFERENCE : JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 193,23,1975 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 32 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - tremor Behavioral - ataxia REFERENCE : JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 193,23,1975 *** END OF RECORD ***